Heart Failure (Congestive Heart Failure).
Shams P, Malik A, Chhabra L.
2025 Feb 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Increased plasma level of apelin with NYHA grade II and III but not IV.
Han L, Jie B, Luo J, Chen L, Jia Y, Guo L, Zhao Y, Chen X, Zhu X, Teng X, Qi Y.
Amino Acids. 2020 May;52(5):823-829. doi: 10.1007/s00726-020-02855-y. Epub 2020 May 9.
Effect of low-level laser physiotherapy on left ventricular function among patients with chronic systolic heart failure.
Sayed MA, El-Sherif RM, Ismail A, Abou Warda AE, Mohamed AR, El-Sherif AA.
Egypt Heart J. 2023 Feb 13;75(1):12. doi: 10.1186/s43044-023-00337-6.
Combination Use of Ivabradine with Sacubitril/Valsartan: A Review of Clinical Effectiveness and Guidelines [Internet].
Pohar R, MacDougall D.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Feb 13.
Elevated homocysteine levels in patients with heart failure: A systematic review and meta-analysis.
Jin N, Huang L, Hong J, Zhao X, Chen Y, Hu J, Cong X, Xie Y, Pu J.
Medicine (Baltimore). 2021 Aug 20;100(33):e26875. doi: 10.1097/MD.0000000000026875.
Intravenous Iron Technique Evaluation in Chronic Heart Failure With Iron Deficiency Anemia.
Gosavi R, Jadhav NB, Nashte A.
Cureus. 2023 Oct 27;15(10):e47778. doi: 10.7759/cureus.47778. eCollection 2023 Oct.
The specific value of upgrading to left bundle branch area pacing in patients with pacing-induced cardiomyopathy or non-pacing-induced cardiomyopathy related upgrade status: A retrospective study.
Shan Y, Lin M, Sun Y, Zhang J, Jiang H, Fu G, Zhang W, Wang M.
Pacing Clin Electrophysiol. 2023 Jul;46(7):761-770. doi: 10.1111/pace.14723. Epub 2023 May 29.
Role of neopterin as an inflammatory biomarker in congestive heart failure with insights on effect of drug therapies on its level.
Dogheim GM, Amralla MT, Werida RH.
Inflammopharmacology. 2022 Oct;30(5):1617-1622. doi: 10.1007/s10787-022-01028-5. Epub 2022 Jul 25.
Effectiveness and Safety of Sacubitril/Valsartan in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
Mou Y, Qin L, Wang L, Guo Y, Zhang X, Yu J.
Altern Ther Health Med. 2024 Apr;30(4):190-197.
Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III - IV congestive heart failure.
Freudenberger RS, Schwarz RP Jr, Brown J, Moore A, Mann D, Givertz MM, Colucci WS, Hare JM.
Expert Opin Investig Drugs. 2004 Nov;13(11):1509-16. doi: 10.1517/13543784.13.11.1509.
